At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to ≥10% weight reduction with concomitant Taltz and ...

At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to =10% weight reduction with concomitant Taltz and ...

Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of a GLP-1RA vs aspirin.

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Q: My blood pressure is a little high. My doctor is making me do constant at-home testing, take medication and check in with ...

As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...

Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...

Sacramento, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The term "best" reflects common consumer search behavior and is used for informational and exploratory purposes only. It does not imply endorsement, ...

Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.

Nausea is the most common tirzepatide side effect. In Zepbound clinical trials, 25 to 28 percent of people reported nausea. Tirzepatide might cause nausea because it slows the movement of food through ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...